Uncategorized

Podcast

Posted by Hajra Batool

Latest News

Latest News

Your Resource for the Latest News!

We seek to keep you updated on the latest Lupus News, Research, Press Releases and Clinical Trials.

FDA Accepts Supplemental Biologics License Application for Gayzva for Treatment of Lupus Nephritis

 
The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for Gazyva® (Obinutuzumab), for the potential treatment of lupus nephritis, (LN, lupus-related kidney disease). A sBLA is a request submitted to the FDA to approve changes to an already licensed biologic product – in this case, a new indication.

“In people with lupus nephritis, Gazyva/Gazyvaro demonstrated a complete renal response benefit, a meaningful clinical outcome linked to preservation of kidney function, and slowing or prevention of end-stage kidney disease,” said Levi Garraway, M.D., Ph.D., Roche’s Chief Medical Officer and Head of Global Product Development. “The FDA’s sBLA acceptance for Gazyva/Gazyvaro recognises the need to provide a more effective treatment option for people living with this devastating disease.”

Read the full press release here

Obinutuzumab Shows Positive Results for Lupus Nephritis

Lupus Ontario is excited to share share positive news of the Phase 3 REGENCY clinical trial showing benefits of Gazyva® (obinutuzumab) in treating people with active lupus nephritis (inflammation of the kidney associated with lupus). In development as a potential treatment for lupus nephritis, Gazyva is approved in 100 countries for various forms of lymphoma.

The primary endpoint of the Phase 3 REGENCY trial was met, meaning that complete renal response was seen in a higher proportion of people treated with Gazyva plus standard therapy (mycophenolate mofetil and glucocorticoids) at 76 weeks than those given standard therapy alone.

Read the full article here: Genetech – Press Release

PHASE III Results for Roche's Regency Study by Roche

Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people with lupus nephritis

  • The REGENCY study met its primary endpoint, demonstrating statistically significant and clinically meaningful treatment benefits in people with active lupus nephritis
  • Gazyva/Gazyvaro is designed to target an underlying cause of lupus nephritis, aiming to prevent or delay progression to end-stage kidney disease
  • Lupus nephritis is a potentially life-threatening manifestation of an autoimmune disease affecting 1.7 million people worldwide, primarily women; up to one-third of people on current treatments will progress to end-stage kidney disease within 10 years
Read the result REGENCY study press release here

Managing Work, Relationships, & Lupus - Finding the Right Balance by Elizabeth Lo Serro

Living with lupus means constantly adjusting to the fluctuating demands of your health, your career, and your relationships. Some days, it feels like everything is competing for your attention, and managing it all can feel overwhelming. In this post, I’ll share some practical, tangible tips that have helped me balance my work, relationships, and lupus management after living with lupus for over 20 years.

Prioritize Using the Wheel of Life

A key concept that’s helped me find balance is the idea that life isn’t about doing it all— it’s about doing what matters most. This is where the “wheel of life” framework comes in. The wheel is a simple tool that divides your life into different areas — health, relationships, work, personal growth, finances, etc. By evaluating how much energy and time you’re giving to each of these areas, you can identify what needs more focus.

For example, when I’m going through a flare, my wheel shifts, and health becomes the top priority. Recognizing that life is cyclical, and sometimes one area needs more attention than another, has been essential. Here’s a simple exercise you can try:

  • Draw a circle and divide it into segments representing key areas of your life.
  • Rate each area from 1-10 based on how satisfied you are in that area.
  • Reflect: Where can you shift your focus to bring more balance and harmony into your life
    Leverage Workplace Accommodations

One of the most important things I’ve learned is to ask for support at work. Many companies have policies in place to support employees with disabilities, including chronic conditions like lupus. This might include flexible hours, the ability to work from home, or even modified duties during flare-ups.

Some practical tips to navigate accommodations at work or school:

1. Know your rights: In Ontario, the Accessibility for Ontarians with Disabilities Act (AODA) mandates that workplaces must accommodate employees with disabilities.

2. Speak up early: If you’re newly diagnosed or experiencing a flare, set up a meeting with your HR department or supervisor. Discuss accommodations you may need, such as flexible work hours or permission to attend medical appointments during work hours.

3. Don’t be afraid to ask for help: It’s OK to ask for adjustments that will make it easier for you to do your job without sacrificing your health. If you’re unsure about how to ask, consider focusing on what you need most (like extra time for deadlines or less travel) and how it will help you remain productive in the long run.

4. Understand school accommodations: Most educational institutions offer accommodations like extended time for exams, access to notes, or extra time for assignments.

Navigating Flares in Work and Relationships

When a lupus flare hits, it can feel like everything comes to a halt. However, I’ve learned that being transparent and proactive can help ease the pressure. During a flare, it’s important to communicate clearly about what you need from others — both at work and in personal relationships.

Here are a few tips that work for me:

1. Be upfront: Whether it’s with your boss, coworkers, or loved ones, let them know you’re experiencing a flare and what you need in that moment.

2. Be flexible: Not every flare is the same, and the support you need can change. Take a few moments to reflect on your needs. Sometimes it’s just a matter of reducing your social commitments, while other times you may need full bed rest or to adjust your work schedule.

3. Practice self-compassion: You can’t pour from an empty cup. If you’re constantly pushing through pain or fatigue, you’ll burn out. Be gentle with yourself when things don’t go as planned and give yourself permission to rest when you need it.

4. Communicate in relationships: Sometimes lupus makes me withdraw from social activities, and it’s important to explain why to my friends and family. Being open helps prevent misunderstandings and ensures you get the support you need.

Stay Aligned with Your Long-Term Vision

It’s easy to get frustrated when your body doesn’t want to cooperate with your career or life goals. But I’ve learned that staying aligned with my long-term vision — while being realistic about my health needs — is essential. Sometimes, progress isn’t linear, and that’s okay.

Here’s how I do it:

1. Break goals into small steps: When I feel overwhelmed by my goals, I break them down into manageable tasks. For example, if I have a big work project, I break it into smaller tasks and prioritize the most important ones. This helps me stay productive without overexerting myself.

2. Check in with yourself regularly: I make it a habit to check in with my body, mind, and spirit every week. This helps me assess how I’m feeling and whether I need to adjust my plans.

3. Practice the “long game” mentality: I remind myself that living with lupus means playing the long game. I may not achieve everything I want in a single day, but with consistent effort and self-compassion, I’m still moving forward.

A Holistic Approach

As a health coach, I help other women with lupus reclaim their vitality and confidence, and I use the same principles in my own life. I’ve developed a step-by-step approach that has helped me move from overwhelming pain and fatigue to feeling energized and pain-free.

Through lifestyle medicine, I’ve empowered myself to make sustainable & simple but effective strategies that allow me to take control of my health, listen to my body, and feel confident in managing my lupus.

The learning process hasn’t been easy, but now I know how to thrive despite lupus, rather than just survive.

Balancing work, relationships, and life with lupus isn’t easy, but it’s possible. It requires patience, self-awareness, and the willingness to prioritize what truly matters. Life isn’t about doing everything perfectly; it’s about making the right choices for your health and well-being and understanding that you can adjust as life’s seasons change. By taking it one step at a time and using the strategies I’ve shared, you can create a life that’s manageable, fulfilling, and aligned with your values.

Lupus Ontario funds certification for Advanced Clinician Practitioner in Arthritis Care (ACPAC) in Thunder Bay

In 2023, Vanessa Cava and Abbey Hunter organized the Thunder Bay   WALK for Lupus Ontario. These two lupus warriors wanted to raise   awareness and were committed to raising funds to support those living   with lupus in their community. Their dedication allowed them to raise   over $20,000 for Thunder Bay. Since that time Lupus Ontario has been   working with St. Joseph’s Care Group in Thunder Bay to develop a plan   to support the Rheumatic Diseases Program.

The Rheumatic Diseases Program triages over 600 referrals a year to rheumatology services and other programs in the community to support people living with rheumatic diseases.

Lupus Ontario is proud to announce that we will be funding Kathleen Andrews, a staff member of St. Joseph’s Care Group to pursue her certification as an Advanced Clinician Practitioner in Arthritis Care (ACPAC). This will enhance support for the Rheumatic Diseases program.

Kathleen has been working as an Occupational Therapist for the past 22 years in Thunder Bay (with a 1-year stint in Edmonton in the Arthroplasty program at the Royal Alexandra Hospital). She has an active interest in arthritis since volunteering within the Rheumatic Diseases Program at St. Joseph’s Care Group as a university student. The rewarding experience of volunteering within that environment played a key role in her decision to become an Occupational Therapist. Kathleen graduated from McMaster University in 2002 and has gained experience in various areas of Occupational Therapy, including within the Rheumatic Diseases Program. Currently, Kathleen works in outpatient orthopedics and with older adults in the geriatric assessment program.

“Having been born, raised, and working the vast majority of my career in Thunder Bay, I have been able to garner firsthand experience in the unique challenges we face in Northwestern Ontario with respect to access to rheumatological care for our clients. A lack of specialists, coupled with a vast geographical area makes access to care at times very difficult for our clients. I feel strongly about the need for equitable and efficient access to care for our clients and I look forward to being a part of the solution to the challenges they face. I am honoured to be receiving a funding grant through Lupus Ontario to be able to partake in this education and continue to serve our clients to the best of my ability.”

– Kathleen Andrews

Kathleen – We wish you all the best in your studies and as you move forward in your new role!

Special thanks to Vanessa Cava, Abbey Hunter, St. Joseph’s Care Group, Tbaytel, RBC and the many donors who supported the 2023 Thunder Bay WALK for Lupus Ontario.

The 16th International Congress on Systemic Lupus Erythematosus (LUPUS 2025), will be held from May 21-24, 2025 in Toronto, Ontario (at the Westin Harbour Castle) chaired by Dr. Zahi Touma. 
 
This congress will also include patient sessions as follows (all sessions are in-person only):
 
  • Mental Health and lupus
  • Life journey and lupus: fertility preservation, family planning and pregnancy navigation and menopause and HRT
  • Male and lupus
  • Access to lupus care (access to lupus healthcare, challenges such as delayed diagnosis, access to the latest approved drugs and treatments)
  • Racial disparities and lupus
  • Social determinants and lupus
  • Non-pharmacological interventions to improve health in SLE
  • Nutrition and lupus
  • Occupational Therapy and lupus

REGISTER FOR THE LUPUS CONFERENCE 2025 HERE

Please note: The admission is $100 USD for all four days, which includes the sessions, meals and entertainment. There is a hall capacity limit, so you are advised to register early.

Living with Lupus: Effective Pain Management Strategies

By Lisa Bilodeau, Vice President Lupus Ontario for Health Insight

People with various rheumatological diseases, such as lupus, often endure chronic inflammation and pain. While managing this pain can be challenging, several strategies can help alleviate it.

Lupus is an autoimmune disease where the body’s immune system mistakenly attacks its own tissues, leading to inflammation, pain, and potential organ damage. It affects five million people globally, and currently, there is no cure. Individuals with lupus may experience periods of remission between episodes of active disease, known as flares, during which pain can be particularly intense.


Increasing Awareness, 100 women at a time
by Lisa Bilodeau

Lisa Bilodeau, a lupus warrior and active community member, addressed 100+ Women Who Care Burlington and Hamilton-Wentworth to raise awareness about lupus. She shared her personal journey with the condition, highlighting its challenges and the need for increased research and funding. Lisa emphasized the importance of systemic research on lupus, which can benefit other autoimmune and systemic diseases. Both chapters of 100+ Women Who Care supported Lupus Ontario, funding a new support group and the Anne Matheson Biobank. Lisa expressed gratitude for the opportunity to raise awareness and hopes for a future without lupus.

Lupus Ontario is now an official Affiliate Member of the CSPA

The Canadian Skin Patient Alliance (CSPA) is a national non-profit organization dedicated to advocate, educate and support Canadians living with skin diseases, conditions, and traumas. We support and collaborate with Canadian patient groups and organizations that deal with specific skin disorders. By working together, we advocate for the needs of skin patients across the country and provide a broad range of education and support.

2024-2025 Geoff Carr Lupus Fellowship

The annual Fellowship is designed to provide advanced training to a rheumatologist specializing in lupus at an Ontario Lupus Clinic. The Lupus Fellow will follow patients at an accredited lupus clinic, supervise patient care and education, and become involved in clinical research. The stipend attached to the Geoff Carr Lupus Fellowship will be $72,000 CAD for one year. Candidates must arrange their own place of training at an accredited Lupus Clinic in Ontario.

The successful candidate will likely have completed his/her core training in Internal Medicine or Pediatrics and have completed a minimum of two years in rheumatology.

Awards are made on the recommendation of Arthritis Society Canada’s review panel. Lupus Ontario administers the Fellowship.

New data on SAPHNELO, a promising biologic for lupus

SAPHNELO data show patients are more likely to achieve and sustain remission in systemic lupus erythematosus compared to standard therapy alone

Posted by Hajra Batool

Lupus Ontario Autoimmune Panel Discussion:

November 27, 2021

Our special guests were: 

Linda Keill, President of Lupus Ontario

Dr. Leslie Laing, President of Sjogren’s Society of Canada

Jan Nitti, Board of Directors with Raynaud’s Association of America

Jacqueline Fraser, Fibromyalgia London Group

Danielle Hogg, Occupational Therapist with the Arthritis Society

Overview 

Each panelist provided a 15-minute presentation introducing their role and organization. They then discussed what support/resources/activities they offer their members and how our members can get involved.  There was also a 20-30 minute question and answer period at the end of all the presentations.  

Download PDF’s of the Presentations:

Arthritis Society PDFRaynaud’s Association of America PDFSjogrens Society of Canada PDFFibromyalgia London Group PDF

Posted by abdul

Meet the fellows

Meet the Lupus Ontario Geoff Carr Fellows!

35+ fellows & counting

35+ Years of the Lupus Ontario Geoff Carr Fellowship means, 35+ years of lupus research by our amazing fellows! Learn more about them below.

Geoff Carr Fellowship Recipients

Meet all of the Lupus Ontario Geoff Carr Research fellows, and learn about their research and area of study! 
 
2023-2024
Toronto Western Hospital
Dr. Teresa Semalulu

Exploring racial disparities in disease-related activity and damage in SLE.

2022 - 2023
SickKids Hospital
Dr. Stephanie Wong

Therapeutic drug monitoring of HCQ is feasible in the cSLE population, allowing for individualized HCQ treatment with optimal efficacy and prevention of long- term toxicity.

2021 - 2022
SickKids Hospital
Dr. Tala El Tal

Research focuses in neuropsychiatric (NPSLE), specifically examining the longitudinal prevalence of cognitive impairment and relationship to disease and health-related quality of life in cSLE.

2020 - 2021
Toronto Western Hospital
Dr. Ambika Gupta

Determination of the clinical subtypes of cognitive impairment in SLE patients to facilitate precision health care and better outcomes.

2019 - 2020
Toronto Western Hospital
Dr. Laura Whittal Garcia

The potential role of serum HMGB1 from NETs as a biomarker to predict residual renal inflammation and subsequent flares in patients with lupus nephritis.

2018 -2019
SickKids Hospital
Dr. Anita Dhanrajani

The potential role of serum HMGB1 from NETs as a biomarker to predict residual renal inflammation and subsequent flares in patients with lupus nephritis.

2017-2018
Toronto Western Hospital
Dr. Konstantinos Tselios

Prolonged antimalarial treatment may increase the risk for subclinical heart damage in systemic lupus erythematosus.

2016-2017
SickKids Hospital
Dr. Julie Couture

Depression in paediatric SLE patients.

2015 - 2016
Toronto Western Hospital
Dr. Jorge Medina Rosas

Prolonged antimalarial treatment may increase the risk for subclinical heart damage in systemic lupus erythematosus.

2014 - 2015
Toronto Western Hospital
Dr. Konstantinos Tselios

The management of Arterial Hypertension and Hypercholesterolemia in patients with SLE. Are the current treatment guidelines adequate for lupus patients?

2013 - 2014
McMaster University
Dr. Kim Legault

Pathophysiology of cognitive dysfunction in patients with antiphospholipid antibodies and lupus.

2012 - 2013
Toronto Western Hospital
Dr. Barry Sheane

Cardio vascular risks in patients with SLE.

2011 - 2012
Toronto Western Hospital
Dr. Amanda Steiman

Predicting flares in patients who are serologically active and and clinically quiescent.

2010 - 2011
Dr. Zahi Touma

SRI-50 Index which is used to measure disease activity.

2009 - 2010
McMaster University
Dr. Derek Haaland

Lupus Nephritis.

2008 -2009
SickKids Hospital
Dr. Satish Kumar

Long term outcome of children with SLE with emphasis on the Central Nervous System 

2008 -2009
Toronto Western Hospital
Dr. Zahi Touma

Outcome measures used in clinical trials in SLE in order to find an optimal measure.

2007-2008
Toronto Western Hospital
Dr. Desiree Tulloch-Reid

Lupus Nephritis.

2006-2007
Dr. Mandana Nikpour

Atherscerlosis in SLE

2005-2006
Toronto Western Hospital
Dr. Zhaleh Shariati

Definition of thrombitis risk associated with anticardiolipin antibofy in SLE

2004-2005
Toronto Western Hospital
Dr. Mandana Nikpour

Vascular disease in systemic Lupus Erythematosus

2003-2004
SickKids Hospital
Dr. Susanne Benseler

Methods to improve paediatric Lupus treatment.

2002-2003
Toronto Lupus Clinic
Dr. Adrienne Williamson
2001-2002
Dr. Marie Feletar

Impact of the updated 1997 revised criteria for classification of SLE, Prolonged remission in SLE

2000-2001
Toronto Lupus Clinic
Dr. Dana Jerome

The effective of menopause on disease activity in SLE

1999-2000
Dr. Anna Jaroszynska

Bone mineral density in premenopausal females with SLE

1998-1999
Toronto Lupus Clinic
Dr. Santiago Aguero
1997-1998
SickKids Hospital
Dr. Stefan Hagelberg

Pathogenic mechanisms in lupus patients with CNS involvement

1996-1997
University of Toronto
Dr. Ian Bruce

Assess the prevalence of ischemic heart disease in patients with SLE, current management of risk factors for coronary artery disease

1995-1996
McMaster University
Dr. Sergio Toloza
1994-1995
The Wellesley Hospital / University of Toronto
Dr. Vandana Chaudry

Osteonecrosis in SLE

1993-1994
The Wellesley Hospital / University of Toronto
Dr. Mahmood Abu-Shakra
  • Anticardiolipin Antibodies in SLE: Clinical and Laboratory Correlations
  • The Significance of Anticardiolipin Antibodies in patients with Lupus Nephritis
1992-1993
The Wellesley Hospital / University of Toronto
Dr. Julie Kovacs

Single Photon Emission Computerized Tomography (SPECT) in Neuropsychiatric SLE

1991-1992
The Wellesley Hospital / University of Toronto
Dr. Rachel Pauzner
  • Prolactin in SLE
  • Anti-neutrophil Cytoplasmic Antibodies (ANCA) in SLE
  • Evaluation of predictive factors for neurocognitive dysfunction in patients with SLE
1990-1991
The Wellesley Hospital / University of Toronto
Dr. Barbara Walz-Leblanc

Serologically Active Clinically Quiescent Systemic Lupus Erythematosus (SLE) - Predictors of Clinical Flares

Posted by Hajra Batool

Geoff Carr Fellowship

Lupus Ontario Geoff Carr Fellowship

Applications for the 2025-26 year are now closed.

The Annual Lupus Ontario Geoff Carr Fellowship was established in 1990. The project is named for the late Geoff Carr, a member of the Association of Commercial Travellers, and a strong supporter of Lupus Ontario. The Fellowship year is served at an Ontario Lupus clinic. Since 1990, Lupus Ontario has funded the training of 35+ rheumatologists, the majority of them continue to practice in Ontario. The Fellowship is open to applicants from around the world with preference given to Canadians.  

Goal of the Fellowship: to train a rheumatologist to become expert in diagnosing and treating lupus. The Fellow is also required to complete a research project.

Objectives of the Fellowship

  •   Learn best practices of diagnosing lupus.
  •   Learn best practices of treating lupus and of predicting and managing flares.
  •   Participate in a lupus research project.

The value of the Fellowship is described by some of the past Fellows.

Dr. Zahi Touma who currently leads the Lupus Clinic at Toronto Western Hospital states:

‘Supporting research is crucial, and one effective way to do this is through the Geoff Carr Fellowship. Research is essential for developing future lupus scientists, researchers, and healthcare professionals who manage lupus.’

Dr. Amanda Steiman, who currently leads the Young Adult SLE Clinic at Mount Sinai Hospital, Toronto, states:

“The Geoff Carr Lupus Research Fellowship supported my pursuit of advanced training in SLE. I emerged a stronger clinician, researcher and advocate for lupus patients. It allowed me to engage deeply with lupus care and research under the expert supervision of world leaders in the field, it and reinforced my passion for caring for patients with SLE.”

Dr. Barry Sheane, a lupus researcher in Ireland states:

“Lupus is becoming an increasingly treatable disease although challenges remain and there remains a significant shortfall in our knowledge of lupus-related pathology. Through the Geoff Carr Fellowship, rheumatologists with an interest in lupus can be facilitated in their pursuit of increasing our knowledge base with the ultimate goal of improving the quality of life of lupus sufferers.”

Geoff Carr Fellow Timeline

2024-2025
Toronto Western Hospital
Dr.Justin Smith
2023-2024
Toronto Western Hospital
Dr. Teresa Semalulu

Exploring racial disparities in disease-related activity and damage in SLE.

2022 - 2023
SickKids Hospital
Dr. Stephanie Wong

Therapeutic drug monitoring of HCQ is feasible in the cSLE population, allowing for individualized HCQ treatment with optimal efficacy and prevention of long- term toxicity.

2021 - 2022
SickKids Hospital
Dr. Tala El Tal

Research focuses in neuropsychiatric (NPSLE), specifically examining the longitudinal prevalence of cognitive impairment and relationship to disease and health-related quality of life in cSLE.

2020 - 2021
Toronto Western Hospital
Dr. Ambika Gupta

Determination of the clinical subtypes of cognitive impairment in SLE patients to facilitate precision health care and better outcomes.

2019 - 2020
Toronto Western Hospital
Dr. Laura Whittal Garcia

The potential role of serum HMGB1 from NETs as a biomarker to predict residual renal inflammation and subsequent flares in patients with lupus nephritis.

2018 -2019
SickKids Hospital
Dr. Anita Dhanrajani

The potential role of serum HMGB1 from NETs as a biomarker to predict residual renal inflammation and subsequent flares in patients with lupus nephritis.

2017-2018
Toronto Western Hospital
Dr. Konstantinos Tselios

Prolonged antimalarial treatment may increase the risk for subclinical heart damage in systemic lupus erythematosus.

2016-2017
SickKids Hospital
Dr. Julie Couture

Depression in paediatric SLE patients.

2015 - 2016
Toronto Western Hospital
Dr. Jorge Medina Rosas

Prolonged antimalarial treatment may increase the risk for subclinical heart damage in systemic lupus erythematosus.

2014 - 2015
Toronto Western Hospital
Dr. Konstantinos Tselios

The management of Arterial Hypertension and Hypercholesterolemia in patients with SLE. Are the current treatment guidelines adequate for lupus patients?

2013 - 2014
McMaster University
Dr. Kim Legault

Pathophysiology of cognitive dysfunction in patients with antiphospholipid antibodies and lupus.

2012 - 2013
Toronto Western Hospital
Dr. Barry Sheane

Cardio vascular risks in patients with SLE.

2011 - 2012
Toronto Western Hospital
Dr. Amanda Steiman

Predicting flares in patients who are serologically active and and clinically quiescent.

2010 - 2011
Dr. Zahi Touma

SRI-50 Index which is used to measure disease activity.

2009 - 2010
McMaster University
Dr. Derek Haaland

Lupus Nephritis.

2008 -2009
SickKids Hospital
Dr. Satish Kumar

Long term outcome of children with SLE with emphasis on the Central Nervous System 

2008 -2009
Toronto Western Hospital
Dr. Zahi Touma

Outcome measures used in clinical trials in SLE in order to find an optimal measure.

2007-2008
Toronto Western Hospital
Dr. Desiree Tulloch-Reid

Lupus Nephritis.

2006-2007
Dr. Mandana Nikpour

Atherscerlosis in SLE

2005-2006
Toronto Western Hospital
Dr. Zhaleh Shariati

Definition of thrombitis risk associated with anticardiolipin antibofy in SLE

2004-2005
Toronto Western Hospital
Dr. Mandana Nikpour

Vascular disease in systemic Lupus Erythematosus

2003-2004
SickKids Hospital
Dr. Susanne Benseler

Methods to improve paediatric Lupus treatment.

2002-2003
Toronto Lupus Clinic
Dr. Adrienne Williamson
2001-2002
Dr. Marie Feletar

Impact of the updated 1997 revised criteria for classification of SLE, Prolonged remission in SLE

2000-2001
Toronto Lupus Clinic
Dr. Dana Jerome

The effective of menopause on disease activity in SLE

1999-2000
Dr. Anna Jaroszynska

Bone mineral density in premenopausal females with SLE

1998-1999
Toronto Lupus Clinic
Dr. Santiago Aguero
1997-1998
SickKids Hospital
Dr. Stefan Hagelberg

Pathogenic mechanisms in lupus patients with CNS involvement

1996-1997
University of Toronto
Dr. Ian Bruce

Assess the prevalence of ischemic heart disease in patients with SLE, current management of risk factors for coronary artery disease

1995-1996
McMaster University
Dr. Sergio Toloza
1994-1995
The Wellesley Hospital / University of Toronto
Dr. Vandana Chaudry

Osteonecrosis in SLE

1993-1994
The Wellesley Hospital / University of Toronto
Dr. Mahmood Abu-Shakra
  • Anticardiolipin Antibodies in SLE: Clinical and Laboratory Correlations
  • The Significance of Anticardiolipin Antibodies in patients with Lupus Nephritis
1992-1993
The Wellesley Hospital / University of Toronto
Dr. Julie Kovacs

Single Photon Emission Computerized Tomography (SPECT) in Neuropsychiatric SLE

1991-1992
The Wellesley Hospital / University of Toronto
Dr. Rachel Pauzner
  • Prolactin in SLE
  • Anti-neutrophil Cytoplasmic Antibodies (ANCA) in SLE
  • Evaluation of predictive factors for neurocognitive dysfunction in patients with SLE
1990-1991
The Wellesley Hospital / University of Toronto
Dr. Barbara Walz-Leblanc

Serologically Active Clinically Quiescent Systemic Lupus Erythematosus (SLE) - Predictors of Clinical Flares

Posted by Hajra Batool

Biobank

The Lupus Ontario Anne Matheson Biobank

Your Gift Supports...

The Lupus Ontario Anne Matheson Biobank is located at McMaster University, Thrombosis and Atherosclerosis Research Institute. Samples for the Biobank are drawn at the Boris Clinic (where lupus patients are treated) within McMaster University Health Sciences.

The Biobank will provide an important bioresource for researchers to study lupus and may help to provide answers, allowing physicians to better diagnose the condition and predict potential problems.

The Lupus Ontario Anne Matheson Biobank is overseen by Dr. Tselios and his research team. The Biobank will include samples of serum, urine, and DNA from consenting lupus patients. Not only will the research team collect samples, but they will also collect information about the patients through quality-of-life indicators, pain and fatigue questionnaires, and anxiety & depression inventories.

Our Contribution

Lupus Ontario has made an annual commitment of $50,000 per year for three years to fund the first year of the start up and next two years of operations at McMaster University in Hamilton. McMaster has agreed to name the biobank the Lupus Ontario Anne Matheson Biobank. This project is being led by one of Lupus Ontario's former Geoff Carr Fellows, Dr. Konstantinos Tselios.

Anne Matheson

Anne Matheson is passionate about the need for support and factual information for lupus patients and their families and has put in years of contribution towards the Lupus Society of Hamilton and Lupus Ontario. While Anne stepped back from her duties with Lupus Ontario in 2014, her legacy will live on through the establishment of the Lupus Ontario Anne Matheson Biobank at McMaster University in Hamilton.
Thank you Anne for all you have done for the lupus community. You are an inspiration to us all!

Objectives

The objectives of the biobank are: 

  • The major goal of the clinic will be the development of an electronic database along with an automated mode of data entry. The plan is to utilize the same software that is being currently used at the Toronto Lupus Clinic at Toronto Western Hospital (TWH). This will allow for easy access and routine use by physicians , excellent technical support and data storage that will facilitate the merge with other databases for further analysis. 
  • An additional goal is the establishment of a biobank, a storage facility for biological samples that will include serum, urine and DNA samples from consenting lupus patients. The software that will be utilized to monitor the samples will be similar or compatible to that of the Toronto Lupus Clinic (TWH). 
  • The biobank will provide valuable data for use in future Lupus Research Projects

Milestones

The major milestones for the project are: 

1. Hire a research assistant (part-time) exclusively for the Lupus Clinic Registry and biobank 

2. Define policies, procedures, protocols 

3. Install technical infrastructure – in addition to the computer equipment and software, this also requires a -80 degree freezer.  Initially, the biobank (actual samples) will be hosted in the freezers of the McMaster Immunology Research Centre.

4. Biobank operational and sample collection 

5.  Ongoing target number of samples to be collected each year is 750 – 1000 (assuming 150 to 200 patients)   

*Dr. Tselios will provide Lupus Ontario with quarterly updates as to the progress of the project.

Lupus Samples biobank
Posted by Hajra Batool